Scinovex
article Open AccessTop 1% cited

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Hepatology · 2014 · Vol. 61(5) · pp. 1547–1554
Mattias EkstedtHannes HagströmPatrik NasrMats FredriksonPer StålStergios KechagiasRolf Hultcrantz

Abstract

NAFLD patients have increased risk of death, with a high risk of death from cardiovascular disease and liver-related disease. The NAS was not able to predict overall mortality, whereas fibrosis stage predicted both overall and disease-specific mortality.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and TransplantationStage (stratigraphy)MedicineFibrosisInternal medicineDiseaseGastroenterologyBiology

MeSH terms

FemaleFollow-Up StudiesHumansLiver CirrhosisMaleMiddle AgedPrognosisSeverity of Illness IndexTime FactorsCohort StudiesNon-alcoholic Fatty Liver Disease
Citations
2,228
FWCI
71.86
field-weighted impact
References
39
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.